CIPO Patents = 1

EPO Patents = 3

Forward Citations = 25

Loading Chart...

4 inventors (with patents filed for the assignee):

Farshid Guilak (6 out of 13 patents)

Bradley T Estes (6 out of 56 patents)

Franklin Thomas Moutos (5 out of 5 patents)

4. Hani Awad (1 out of 5 patents)

5. Arthur W Wu (0 patent)

6 patents: Sort by Forward Citations

1. 11357889 - Native soft tissue matrix for therapeutic applications (2022-06-14),

2. 11109975 - Articular cartilage repair (2021-09-07),

3. 10940007 - Articular cartilage repair (2021-03-09),

4. 10022231 - Articular cartilage repair (2018-07-17),

5. 9649409 - Tissue engineering methods and compositions (2017-05-16),

6. 8691542 - Tissue engineering methods and compositions (2014-04-08),

Company Overview

Cytex Therapeutics, Inc. is a biotechnology company focused on developing innovative regenerative medicine solutions for osteoarthritis and other orthopedic conditions. Our proprietary technology harnesses the power of cell therapy to stimulate tissue regeneration and repair, offering new hope for patients suffering from joint pain and immobility. Visit our website to learn more about our cutting-edge research and potential treatment options.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#111 in Durham, NC

#981 in North Carolina

#45,007 in US

Durham, NC, United States of America

Cytex Therapeutics, Inc.

Forward Citations = 25

4 inventors:

Farshid Guilak (6 out of 13 patents)

Bradley T Estes (6 out of 56 patents)

Franklin Thomas Moutos (5 out of 5 patents)

4. Hani Awad (1 out of 5 patents)

5. Arthur W Wu (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytex Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cytex-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]